Ligand Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Amgen USD 33.53B 140M 2024-12
Arrowhead Research USD 218K 1000 2024-12
Baxter International USD 683M 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
Glaxosmithkline GBP 1.35B 0 2024-12
Insmed USD 1.79M 6K 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
Ligand Pharmaceuticals USD 20K 1000 2024-12
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2024-12
Pacira USD 47K 0 2024-12
Pfizer USD 480M 0 2024-12
Veracyte USD 78K 1000 2024-12



Ligand Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.